Authors: Snydman, DR Jacobus, NV McDermott, LA Supran, SE

Citation: Dr. Snydman et al., Comparative in vitro activities of clinafloxacin and trovafloxacin against1,000 isolates of Bacteroides fragilis group: Effect of the medium on testresults, ANTIM AG CH, 44(6), 2000, pp. 1710-1712

Authors: Snydman, DR Jacobus, NV McDermott, LA Lonks, JR Boyce, JM

Citation: Dr. Snydman et al., Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens, ANTIM AG CH, 44(12), 2000, pp. 3447-3450

Authors: Petersen, PJ Jacobus, NV Weiss, WJ Sum, PE Testa, RT

Citation: Pj. Petersen et al., In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936), ANTIM AG CH, 43(4), 1999, pp. 738-744

Authors: Weiss, WJ Petersen, PJ Jacobus, NV Lin, YI Bitha, P Testa, RT

Citation: Wj. Weiss et al., In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems, ANTIM AG CH, 43(3), 1999, pp. 454-459

Authors: Weiss, WJ Mikels, SM Petersen, PJ Jacobus, NV Bitha, P Lin, YI Testa, RT

Citation: Wj. Weiss et al., In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems, ANTIM AG CH, 43(3), 1999, pp. 460-464

Authors: Snydman, DR Jacobus, NV McDermott, LA Supran, S Cuchural, GJ Finegold, S Harrell, L Hecht, DW Iannini, P Jenkins, S Pierson, C Rihs, J Gorbach, SL

Citation: Dr. Snydman et al., Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996, ANTIM AG CH, 43(10), 1999, pp. 2417-2422